U.S. researcher starts treatment fund in Uganda: interview with David Bangsberg, M.D., M.P.H
- PMID: 15272457
Item in Clipboard
U.S. researcher starts treatment fund in Uganda: interview with David Bangsberg, M.D., M.P.H
AIDS Treat News.
.
Abstract
$400 a year will save a life in Uganda. A U.S. scientist who works there has created a fund that has guaranteed five years of treatment for ten people so far.
Similar articles
-
Kenya says yes to generic ARVs but fails to win Global Fund cash.Bull World Health Organ. 2002;80(7):608. Bull World Health Organ. 2002. PMID: 12163933 Free PMC article. No abstract available.
-
Generic drugs battle moves from South Africa to Kenya.Lancet. 2001 May 19;357(9268):1600. doi: 10.1016/S0140-6736(00)04794-2. Lancet. 2001. PMID: 11377665 No abstract available.
-
Access to essential medications for HIV/AIDS in South Africa.S Afr Med J. 2001 May;91(5):384-7. S Afr Med J. 2001. PMID: 11455797 Review. No abstract available.
-
Global fund decides to promote use of generic drugs.Can HIV AIDS Policy Law Rev. 2002 Dec;7(2-3):58-9. Can HIV AIDS Policy Law Rev. 2002. PMID: 14740604 English, French. No abstract available.
-
Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries? .Int J Clin Pharmacol Ther. 2017 May;55(5):381-393. doi: 10.5414/CP202775. Int J Clin Pharmacol Ther. 2017. PMID: 28211784 Review.
Cited by
-
Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues.AIDS Behav. 2007 Mar;11(2):161-73. doi: 10.1007/s10461-006-9133-3. AIDS Behav. 2007. PMID: 16804749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical